Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2009
10/22/2009WO2009127130A1 Achyranthes bidentata polypeptide and production methods and uses thereof
10/22/2009WO2009114831A3 Process to produce fibrillar proteins and method of treating using fibrillar proteins
10/22/2009WO2009111727A4 Compositions comprising ghrh and gnrh and methods of using the same
10/22/2009WO2009106819A3 Biological materials and uses thereof
10/22/2009WO2009106715A3 Peptide derived from a protein of the aquaporin family
10/22/2009WO2009105783A4 Cosmetic and dermatological formulations of mntf peptides
10/22/2009WO2009102357A3 Hiv-1 envelope glycoprotein oligomer and methods of use
10/22/2009WO2009102172A3 Pharmaceutical formulation containing choline alfoscerate
10/22/2009WO2009100348A3 Peptides and peptide mimetics to treat pathologies associated with eye disease
10/22/2009WO2009100218A3 Kruppel-like transcription factor klf4/gklf and uses thereof
10/22/2009WO2009099777A3 Chimeric hiv fusion proteins as vaccines
10/22/2009WO2009099467A3 Cyclosporin compositions
10/22/2009WO2009093864A3 Composition for preventing or treating brain diseases
10/22/2009WO2009088992A3 Ribonuclease and thiazolidinedione compounds and their use in methods to treat cancer
10/22/2009WO2009086400A3 Recombinant vwf formulations
10/22/2009WO2009073725A9 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
10/22/2009WO2009065857A3 Compositions for reducing oxidative stress and uses thereof
10/22/2009WO2009046827A3 Use of growth hormone-releasing factor and/or mage-3 antigen (271-279) as therapeutic agents
10/22/2009WO2009043518A3 Use of a combination of cart peptides as a therapeutic agent
10/22/2009WO2009040050A3 Use of calcitonin as anti-angiogenic agent
10/22/2009WO2009040048A3 Use of the c-reactive peptide as a therapeutic agent
10/22/2009WO2009040036A3 Use of a galanin peptide as a therapeutic agent
10/22/2009WO2009039982A3 Use of gip alone or in combination with dynorphin b as a therapeutic agent
10/22/2009WO2009039972A3 Use of muramyl dipeptide (mdp) as a therapeutic agent
10/22/2009WO2009037191A3 Use of g-csf for the treatment of stroke
10/22/2009WO2009033810A3 Use of antioxidant peptide a (phckrm) and aplha-casein (90-96) as therapeutic agents in eg the treatment of hiv infection
10/22/2009WO2009004339A3 Modulation of reactive oxygen species in the treatment of respiratory infection
10/22/2009WO2007125210A8 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
10/22/2009WO2002087504A9 Methods for inhibiting tumor cell proliferation
10/22/2009WO2001000878A9 A novel vascular endothelial growth factor family member and uses thereof
10/22/2009US20090264921 Adhesive hemostatic agent based on porcine atelocollagen and method for production thereof
10/22/2009US20090264636 Conjugates and compositions for cellular delivery
10/22/2009US20090264634 Sequences characteristic of hypoxia-regulated gene transcription
10/22/2009US20090264625 Method for recombinant microorganism expression and isolation of collagen-like polypeptides
10/22/2009US20090264624 Human cytokine receptor
10/22/2009US20090264537 Biodegradable block copolymeric compositions for drug delivery
10/22/2009US20090264515 Polynucleotide therapy
10/22/2009US20090264505 Methods and compositions for rnai mediated inhibition of gene expression in mammals
10/22/2009US20090264487 Hemiasterlin analogs
10/22/2009US20090264419 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
10/22/2009US20090264381 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/22/2009US20090264373 Synthetic peptide amides and dimers thereof
10/22/2009US20090264372 Utilization of peptides as active ingredients for slimming
10/22/2009US20090264371 Antiproliferative peptides and antibodies for their detection
10/22/2009US20090264370 Polypeptides homologous to vegf and bmp1
10/22/2009US20090264369 Methods for reducing cd36 expression
10/22/2009US20090264368 Compositions for delivering parathyroid hormone and calcitonin
10/22/2009US20090264367 5-cnac as oral delivery agent for parathyroid hormone fragments
10/22/2009US20090264366 Transglutaminase Mediated Conjugation of Peptides
10/22/2009US20090264365 Conformationally constrained parathyroid hormone (pth) analogs
10/22/2009US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
10/22/2009US20090264363 Leucine-Rich Peptide Compositions and Methods for Isolation
10/22/2009US20090264362 Influenza virus inhibiting peptides
10/22/2009US20090264361 Identification of a family of secreted proteins in vascular endothelium
10/22/2009US20090264360 Cloning and expression of gonadotropin-releasing hormone (GnRH) receptors
10/22/2009US20090264359 Fplr-1 inhibitors for use in diseases involving amyloid-induced inflammatory events (flipr and flipr-like) and immunecomplex-mediated diseases
10/22/2009US20090264358 Vegf receptor fusion proteins, their pharmaceutical compositions and therapeutic applications for the eye diseases
10/22/2009US20090264357 NOVEL AGENT THAT INHIBITS ANGIOGENESIS AND METASTASIS TARGETING mTOR SIGNALING PATHWAY
10/22/2009US20090264356 Adenovirus 36 E4 orf 1 Gene and Protein and Their Uses
10/22/2009US20090264355 Methods to treat alzheimer's disease or other disorders mediated by amyloid-beta accumulation in a subject
10/22/2009US20090264354 Penumbra Nucleic Acid Molecules, Proteins and Uses Thereof
10/22/2009US20090264353 Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
10/22/2009US20090264352 Use of glp-1 and agonists thereof to prevent cardiac myocyte apoptosis
10/22/2009US20090264350 Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
10/22/2009US20090264349 CD30 Ligand
10/22/2009US20090264348 Treatment with cyclosporin a
10/22/2009US20090264347 Use of Blood Coagulation Factor XIII for Treating Hemophilia A
10/22/2009US20090264346 Macrocyclic peptides active against the hepatitis c virus
10/22/2009US20090264345 Macrocyclic peptides and methods for making and using them
10/22/2009US20090264344 cyclic polypeptide biodrug; NONHEMOLYTIC, MINIMAL IN VITRO CYTOTOXICITY; TREATMENT OF BACTERIAL, VIRAL INFECTION, ESPECIALLY ONE CAUSED BY HIV-1 RETROVIRUS OR OTHER SEXUALLY-TRANSMITTED PATHOGENS
10/22/2009US20090264343 Method of producing fr901228
10/22/2009US20090264342 Compositions and methods for antibiotic potentiation and drug discovery
10/22/2009US20090264341 Purified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disorders
10/22/2009US20090264340 Compositions and methods for increasing the oral absorption of antimicrobials
10/22/2009US20090264339 Heterocyclic Compounds
10/22/2009US20090264338 Inhibitor of Insulin Multimer Formation
10/22/2009US20090264337 Cellular GPRS-communication linked glucometer - pedometer
10/22/2009US20090264336 glucokinase activator 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide or a salt ; deprotecting silanol group with an acid; type 2 diabetes
10/22/2009US20090264303 Polypeptides having a functional domain of interest and methods of identifying and using same
10/22/2009US20090263916 Antagonists of HMG1 for treating inflammatory conditions
10/22/2009US20090263898 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
10/22/2009US20090263886 Farnesyl dibenzodiazepinone and processes for its production
10/22/2009US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
10/22/2009US20090263783 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
10/22/2009US20090263522 Curcuminoid Compositions Exhibiting Synergistic Inhibition Of The Expression And/Or Activity Of Cyclooxygenase-2
10/22/2009US20090263516 Plant Extract Composition and Their Use to Modulate Cellular Activity
10/22/2009US20090263484 Tissue Engineering Devices and Methods for Luminal Organs
10/22/2009US20090263474 Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
10/22/2009US20090263473 Nanoliposome Using Esterified Lecithin And Method For Preparing The Same, And Composition For Preventing Or Treating Skin Diseases Comprising The Same
10/22/2009US20090263472 Endothelin receptor antagonist derivatives
10/22/2009US20090263467 Combination drug therapy using orally dissolving film or orally disintegrating tablet dosage forms to treat dry mouth ailments
10/22/2009US20090263452 Drug-eluting intravascular prostheses and methods of use
10/22/2009US20090263429 Method of Preparing a Hydrogel
10/22/2009US20090263426 Methods for treating headache
10/22/2009US20090263425 Methods of stimulating an immune response against prostate specific antigen
10/22/2009US20090263412 Non-Splicing Variants of gp350/220
10/22/2009US20090263408 Formulation and presentation of medicaments
10/22/2009US20090263407 Cationic Lipids and Uses Thereof
10/22/2009US20090263406 JY-1 Regulation Of Granulosa Cell Function And Early Embryonic Development In Cattle
10/22/2009US20090263403 DNAX Accessory Protein, 12 kD (DAP12); useful in modulating development of cells such as lymphoid and myeloid; for modulating of immune responses; fusion proteins
1 ... 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 ... 3163